Ar. Judkins et al., SENSITIVITY AND SPECIFICITY OF ANTIBODIES ON NECROTIC TUMOR-TISSUE, AJCP. American journal of clinical pathology, 110(5), 1998, pp. 641-646
Immunohistochemistry occasionally is used to determine the lineage of
entirely necrotic tumors. However the sensitivity and specificity of a
ntibodies on necrotic tissue are unknown. To determine the usefulness
of immunohistochemistry with necrotic lesions, a series of 24 known tu
mors consisting of 14 carcinomas, 2 lymphomas, 2 melanomas, and 6 sarc
omas (all with extensive necrosis) was examined for reactivity with 6
cytokeratin antibodies, S100, and LCA. Carcinomas stained positively w
ith at least I cytokeratin antibody in 78% of the cases. The cytokerat
in antibodies with the highest sensitivity were AE1, AE1/3, S903, and
PANCK. These antibodies also retained specificity for epithelial diffe
rentiation; no reactivity was observed in the 10 necrotic nonepithelia
l tumors. LCA retained its reactivity with necrotic lymphoma, but S100
reacted with only one third of the necrotic lesions. Unexpectedly, re
activity for LCA and S100 occurred in some necrotic carcinomas. Kerati
n markers can be used on necrotic tissue to determine epithelial diffe
rentiation, but the results obtained with S100 and LCA on necrotic tis
sue should be interpreted with caution.